Activation of mitogen-activated protein kinases during human lung transplantation

Shoji Sakiyama1, Julia Hamilton, Bing Han

  • 1Thoracic Surgery Research Laboratory, University Health Network Toronto General Hospital and Department of Surgery and Institute of Medical Science, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.

Abstract

Insights

Lung transplantation involves ischemia-reperfusion injury. This study found that early reperfusion activates specific mitogen-activated protein kinases (MAPKs), namely ERK and JNK, potentially contributing to lung graft inflammation and cell death.

Area of Science:

  • Transplantation immunology
  • Molecular biology
  • Cell signaling

Background:

  • Ischemia-reperfusion is a critical event in lung transplantation, leading to inflammation and cell death.
  • The precise intracellular signaling pathways involved remain largely unknown.
  • Mitogen-activated protein kinases (MAPKs) are hypothesized to play a role in these responses.

Purpose of the Study:

  • To investigate the role of MAPK signaling pathways in human lung transplantation.
  • To examine the activation status of ERK, p38-MAPK, and JNK during lung reperfusion.

Main Methods:

  • Lung tissue biopsies were collected from 15 transplant patients at various stages: cold preservation, warm ischemia, and 1-2 hours post-reperfusion.
  • Western blotting was employed to assess the phosphorylation status of ERK, p38-MAPK, and JNK.

Main Results:

  • ERK phosphorylation significantly increased within the first 2 hours of reperfusion.
  • JNK phosphorylation also showed a significant, albeit lower, increase.
  • No significant changes were observed in p38-MAPK phosphorylation.

Conclusions:

  • Early reperfusion in lung transplantation leads to rapid activation of ERK and JNK.
  • These activated MAPKs may contribute to acute inflammatory responses and cell death in lung grafts.
  • Further research into MAPK inhibition could offer therapeutic strategies for lung transplantation.